Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  European Heart Journal

• Publication date

  2011-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/eurheartj/ehr039PMID 21345850
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Left ventricular outflow tract pseudoaneurysm compromising blood flow through the left main coronary artery after mechanical aortic valve implantation.

  2011cited by this paper
• Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

  2011cited by this paper
• Effects of intensive blood-pressure control in type 2 diabetes mellitus.

  2010cited by this paper
• Effects of individual risk factors on the residual risk of cardiovascular events in a population of treated Chinese patients with hypertension: data from the Felodipine Event Reduction (FEVER) study

  2010cited by this paper
• Blood pressure targets of antihypertensive treatment: up and down the J-shaped curve.

  2010cited by this paper
• Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

  2009cited by this paper
• When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal

  2009cited by this paper
• Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.

  2009cited by this paper
• Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial.

  2009cited by this paper
• Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

  2009cited by this paper
• Telmisartan to prevent recurrent stroke and cardiovascular events.

  2008cited by this paper
• Treatment of hypertension in patients 80 years of age or older.

  2008cited by this paper
• Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

  2008cited by this paper
• Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials.

  2008cited by this paper
• Systolic blood pressure, diabetes and the risk of cardiovascular diseases in the Asia–Pacific region

  2007cited by this paper
• 2013 ESH/ESC Guidelines for the management of arterial hypertension

  2007cited by this paper
• Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

  2007cited by this paper
• Joint Effects of Systolic Blood Pressure and Serum Cholesterol on Cardiovascular Disease in the Asia Pacific Region

  2005cited by this paper
• The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients

  2005cited by this paper
• 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

  2003cited by this paper
• The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

  2003cited by this paper
• Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

  2003cited by this paper
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

  2003cited by this paper
• Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.

  2001cited by this paper
• Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

  2000cited by this paper
• Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

  2000cited by this paper
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

  1998cited by this paper
• Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension

  1998cited by this paper
• Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators.

  1997cited by this paper
• Effect of Antihypertensive Drug Treatment on Cardiovascular Outcomes in Women and Men

  1997cited by this paper
• Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension *

  1997cited by this paper
• Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

  1997cited by this paper
• Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.

  1992cited by this paper
• Medical Research Council trial of treatment of hypertension in older adults: principal results.

  1992cited by this paper
• Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

  1991cited by this paper
• Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

  1991cited by this paper
• Randomised trial of treatment of hypertension in elderly patients in primary care.

  1986cited by this paper
• Mortality and Morbidity Results from the European Working Party on High Blood Pressure in the Elderly Trial

  1986cited by this paper
• Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial.

  1985cited by this paper
• MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.

  1985cited by this paper
• Effect of stepped care treatment on the incidence of myocardial infarction and angina pectoris. 5-Year findings of the hypertension detection and follow-up program.

  1984cited by this paper
• Letter: Immunotherapy for colorectal cancer.

  1976cited by this paper

• Tolerable blood pressure control levels do not impact mortality of patients over 80-year-old: Insights from NHANES 2009-2018.

  2025cites this paper
• Echocardiographic Features of Cardiomyopathies: A Comprehensive Review

  2025cites this paper
• Chinese Guidelines for the Prevention and Treatment of Hypertension (2024 revision).

  2025cites this paper
• Pharmacotherapy for hypertension in adults 60 years or older.

  2025cites this paper
• Higher blood pressure targets for hypertension in older adults.

  2024cites this paper
• Systolic Blood Pressure Control Targets to Prevent Major Cardiovascular Events and Death in Patients With Type 2 Diabetes: A Systematic Review and Network Meta-Analysis

  2023cites this paper
• Hypertension in China: epidemiology and treatment initiatives

  2023cites this paper
• The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension

  2023cites this paper
• Activation of the Vascular Smooth Muscle GLP-1/NCX1 Pathway Regulates Cytoplasmic Ca2+ Homeostasis and Improves Blood Pressure Variability in Hypertension

  2023cites this paper
• Achieved Systolic Blood Pressure and Cardiovascular Outcomes in 60-80-Year-Old Patients: The Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) Trial.

  2023cites this paper
• Optimal blood pressure target in the elderly: rationale and design of the HOW to Optimize eLDerly systolic Blood Pressure (HOWOLD-BP) trial

  2022cites this paper
• Improving outcomes for older hypertensive patients: is more intensive treatment better?

  2022influential citation
• 2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.

  2022cites this paper
• STEP to blood pressure management of elderly hypertension: evidence from Asia

  2022cites this paper
• The Evolution of Hypertension Guidelines Over the Last 20+ Years: A Comprehensive Review

  2022cites this paper
• Cardiovascular disease in diabetes, beyond glucose.

  2021cites this paper
• Associations Between Elevated Systolic Blood Pressure and Outcomes in Critically Ill Patients: A Retrospective Cohort Study and Propensity Analysis

  2021cites this paper
• Prise en charge de l’hypertension artérielle en prévention cardiovasculaire primaire chez les personnes âgées et très âgées

  2021cites this paper
• What is new in the 2018 Chinese hypertension guideline and the implication for the management of hypertension in Asia?

  2020cites this paper
• Clinical outcomes and economic impact of the 2017 ACC/AHA guidelines on hypertension in China

  2019cites this paper
• [Target Levels of Arterial Pressure in Patients with Arterial Hypertension and Stroke].

  2019cites this paper
• PREDICTORS OF ARTERIAL HYPERTENSION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN AZERBAIJAN POPULATION

  2019cites this paper
• 2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension

  2019cites this paper
• 2018 Chinese Guidelines for Prevention and Treatment of Hypertension—A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension

  2019cites this paper
• Pharmacotherapy for hypertension in adults 60 years or older.

  2019cites this paper
• OBJETIVOS TERAPÉUTICOS EN HIPERTENSIÓN ARTERIAL:METAS DE PRESIÓN ARTERIAL EN LOS DIVERSOS SUBGRUPOS DE HIPERTENSOS

  2018cites this paper
• Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 13 – benefits and adverse events in older and younger patients with hypertension overview, meta-analyses and meta-regression analyses of randomized trials

  2018cites this paper
• Blood pressure targets for hypertension in patients with type 2 diabetes.

  2018cites this paper
• OBJETIVOS TERAPÉUTICOS EN HIPERTENSIÓN ARTERIAL:METAS DE PRESIÓN ARTERIAL EN LOS DIVERSOS SUBGRUPOS DE HIPERTENSOS

  2018cites this paper
• Isolated Systolic Hypertension: In the Young and in the Elderly

  2018cites this paper
• Effect Modification by Age on the Benefit or Harm of Antihypertensive Treatment for Elderly Hypertensives: A Systematic Review and Meta-analysis

  2018cites this paper
• Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14 – effects of different classes of antihypertensive drugs in older and younger patients overview and meta-analysis

  2018cites this paper
• [Arterial hypertension, cognitive disorders and dementia: a view of a cardiologist].

  2018cites this paper
• Chinese expert consensus on the diagnosis and treatment of hypertension in the elderly (2017)

  2018cites this paper
• Recommendations for treatment of hypertension in the elderly

  2018cites this paper
• Achieved systolic blood pressure in older people: a systematic review and meta-analysis

  2017influential citation
• Studies of antihypertensive drug persistence and adherence in the Glasgow Blood Pressure Clinic

  2017cites this paper
• Effect of antihypertensive treatment at different blood pressure levels

  2017cites this paper
• Impact of Achieved Blood Pressure on First Stroke in Uncomplicated Grade 1 Hypertension

  2017cites this paper
• Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 – Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials

  2017cites this paper
• Should blood pressure goal be individualized in hypertensive patients?

  2017cites this paper
• Effects of blood-pressure-lowering treatment on outcome incidence in hypertension. 11. Effects of total cardiovascular risk and achieved blood pressure: overview and meta-analyses of randomized trials

  2017cites this paper
• The 2017 Focused Update of the Guidelines of the Taiwan Society of Cardiology (TSOC) and the Taiwan Hypertension Society (THS) for the Management of Hypertension.

  2017cites this paper
• Hypertension in the Oldest Old, Beyond Guidelines

  2017cites this paper
• Risk Factor of Cardiovascular Disease Among Older Individuals

  2017cites this paper
• Combination drug treatment in hypertension

  2017cites this paper
• Blood pressure targets for hypertension in older adults.

  2017cites this paper
• Hypertension artérielle chez le sujet diabétique

  2017cites this paper
• Treatment of uncomplicated hypertension is associated with a reduction in cardiovascular mortality: a Korean national cohort study

  2017cites this paper
• Identifying the optimal blood pressure target for ideal health

  2016cites this paper
• PERFIL ANTROPOMÉTRICO DE USUÁRIOS HIPERTENSOS DE UM PROGRAMA DE SAÚDE DO HOMEM 1

  2016cites this paper
• The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications.

  2016cites this paper
• 7th Brazilian Guideline of Arterial Hypertension: Chapter 11 - Arterial Hypertension in the elderly

  2016cites this paper
• Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses

  2016cites this paper
• Postaerobic Exercise Blood Pressure Reduction in Very Old Persons With Hypertension

  2016cites this paper
• Grupo de Trabajo de Revascularización Miocárdica de la Sociedad Europea de Cardiología (ESC) y la European Association for Cardio-Thoracic Surgery (EACTS) Desarrollada con la colaboración especial de la European Association of Percutaneous Cardiovascular Interventions (EAPCI)

  2016cites this paper
• Hypertension preventive behavior among pre- hypertensive adults in Phutthamonthon district, Nakhon Pathom province, Thailand

  2016cites this paper
• Threshold and Target for Blood Pressure Lowering in the Elderly

  2016cites this paper
• 7TH BRAZILIAN GUIDELINE OF ARTERIAL HYPERTENSION

  2016cites this paper
• What Should Be the Target Blood Pressure in Elderly Patients With Diabetes?

  2016cites this paper
• [Comparison of treatment principles of elderly hypertensive patients with different cardiovascular risks based on Hungarian and international guidelines (2001-2015)].

  2016cites this paper
• [2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)].

  2016cites this paper
• MANEJO DE LA HIPERTENSIÓN ARTERIAL EN DIABETES MELLITUS

  2016cites this paper
• The effect of antihypertensive treatment on the incidence of stroke and cognitive decline in the elderly: a meta-analysis.

  2016cites this paper
• 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment

  2015cites this paper
• Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study

  2015cites this paper
• 2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II—treatments of hypertension

  2015cites this paper
• 2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension.

  2015cites this paper
• Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal.

  2015cites this paper
• The Korean Society of Hypertension Guidelines for the Management of Hypertension in 2013: Its Essentials and Key Points

  2015cites this paper
• 2014 ESC/EACTS guidelines on myocardial revascularization.

  2015cites this paper
• [Differences between the 2013 and 2014 hypertension guidelines.: Position of the Central American and Caribbean Society for Hypertension and Cardiovascular Prevention].

  2015cites this paper
• Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design.

  2015cites this paper
• Relationship of Blood Pressure With Mortality and Cardiovascular Events Among Hypertensive Patients aged ≥60 years in Rural Areas of China

  2015cites this paper
• US Hypertension Management Guidelines: A Review of the Recent Past and Recommendations for the Future

  2015cites this paper
• Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines

  2015cites this paper
• Can Blood Pressure Be Lowered Safely in Older Adults with Lacunar Stroke? The Secondary Prevention of Small Subcortical Strokes Study Experience

  2015cites this paper
• Blood Pressure Control versus Atrial Fibrillation Management in Stroke Prevention

  2015cites this paper
• Hypertonie und Schlaganfall – aktuelle Aspekte beim Diabetespatienten

  2015cites this paper
• Optimal blood pressure targets in 2014 - Does the guideline recommendation match the evidence base?

  2015cites this paper
• [2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation].

  2015cites this paper
• [The Results of Long-Term Observation of Patients Who Participated in the ADVANCE Trial].

  2015cites this paper
• Blood Pressure Lowering in Type 2 Diabetes A Systematic Review andMeta-analysis

  2015cites this paper
• Therapieziele und Indikation zur medikamentösen Therapie bei arterieller Hypertonie: Update 2015 der Empfehlungen der Österreichischen Gesellschaft für Hypertensiologie

  2015cites this paper
• Screening for Abnormal Glucose and Type 2 Diabetes Mellitus: A Systematic Review to Update the 2008 U.S. Preventive Services Task Force Recommendation

  2015cites this paper
• Cardiovascular prevention in older people: The preDIVA trial

  2015cites this paper
• Hypertonie und Schlaganfall - aktuelle Aspekte beim Diabetespatienten

  2015cites this paper
• Wytyczne ESC dotyczące postępowania w ostrych zespołach wieńcowych bez przetrwałego uniesienia odcinka ST w 2015 roku Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) do spraw postępowania w ostrych zespołach wieńcowych bez przetrwałego uniesienia odcinka ST

  2015cites this paper
• Guía de práctica clínica de la ESC sobre revascularización miocárdica, 2014

  2015cites this paper
• [Hypertension in the elderly].

  2015cites this paper
• Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines

  2015cites this paper
• Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines

  2015cites this paper
• Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines

  2015cites this paper
• Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis.

  2015cites this paper
• 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Ca

  2014cites this paper
• ging in blood vessels . Medicinal agents FOR systemic arterial ypertension in the elderly aría

  2014cites this paper
• ESC / EACTS Guidelines on myocardial revascularization

  2014cites this paper
• Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials

  2014cites this paper
• Prevalence and costs of treating uncomplicated stage 1 hypertension in primary care: a cross-sectional analysis

  2014cites this paper
• Drug Safety and Effectiveness Network Report: A Systematic Review with Network Meta-Analyses and Economic Evaluation Comparing Therapies for Hypertension in Non-Diabetic Patients

  2014cites this paper